Experter granskar nanoteknik i mat

Den europeiska livsmedelssäkerhetsmyndigheten EFSA har studerat potentiella risker med nanoteknologi i livsmedel och djurfoder, och rekommenderar försiktighet.

Ingen koppling mellan akrylamid och bröstcancer

En stor amerikansk studie visar att den som äter mycket friterad mat inte löper högre risk att drabbas av bröstcancer än andra.

Mot börsen med kassan full

Det norska cancerforskningsföretaget Algeta tar in 35 miljoner US-dollar för att fortsätta utvecklingen av sitt mest lovande cancerprojekt.

Antikropp mot leukemi

Genmab och Glaxosmithkline har ansökt om marknadsgodkännande hos EMEA för det biologiska leukemiläkemedlet Arzerra, med aktiv substans ofatumumab.

Avhopp i Probis top

Bolagets styrelseordförande lämnar sitt uppdrag.

Säkrare mat med färre myndigheter

Regeringens utredare har nu sett över Sveriges livsmedelsmyndigheter. Hans förslag är att dagens fyra myndigheter ersätts av tre. Syftet är att öka säkerheten, plus spara pengar.

Danskt stöd för ESS till Lund

Stödet växer för att den nya superforskningsanläggningen ska hamna i Lund. Den danska Läkemedelsindustriföreningen ställer sig nu bakom försöken att få ESS till Sverige. Tre kandidater tävlar om miljardsatsningen.

Han blir Alphahelix nya VD

Bolagets tidigare teknikchef tar ett steg upp.

Swedish top scientists to EMBO

Two Swedish top scientists will have a really good chance to influence European life science research from now on. One is from the Karolinska Institutet, and one is from the University of Uppsala.

First ever study of human stem cell treatment

The FDA says yes to the world's first study in man of a human embryonic stem cell based therapy to treat spinal injury.

Grant for development projects in Gothenburg

Seven research projects receive SEK 1 million to promote commercialization of early drug development and medical technology.

Orexo opens doors eastwards

The drug delivery company has signed a deal for selling a cancer pain treatment in China. "An ideal partner for us" says Torbjörn Bjerke, CEO of Orexo.

New member to Active board

The Election Committee of Active Biotech proposes a very experienced financial sector executive to join the company board. Five existing members are also to be re-elected at the AGM in May.

Biotech goes white and bright

White biotech could become Denmark's next blossoming business area.

Top modern lab to Sahlgrenska

The Sahlgrenska Science Park will soon open the doors to a brand new wet laboratory.

Finnish-Dutch engineering cooperation continues

The University of Helsinki and ASM International renew a fice year research agreement on Atomic Layer Deposition.

Positive combined cancer therapy

Topotarget announces positive data with new treatment against colorectal cancer.

Medicult disclaims Swedish offer

The Norwegian company Medicult's Board is highly sceptical to the yesterday announced Vitrolife offer.

LEO Pharma - International Clinical Trial Manager

View pathology images in your iPhone

The Institute for Medical Informatics in Oslo announces a brand new iPhone application for virtual microscopy.

DKK 1,3 billion for grand research

Danish Councils for Independent Research, DFF, will grant DKK 1,3 billion during 2009. Now has the application period started.

Trio goes in for high tech medicines

The Swedish drug discovery company Beactica announces fragment-based drug discovery research collaboration with GE Healthcare and the University of Uppsala.

New influenza vaccine to EU

The Astrazeneca subsidary Medimmune submits marketing authorisationapplication in EU for an new intranasal vaccine against influenza.

Mathematician new dean at DTU

On January 1st the Technical University of Denmark, DTU, got a new dean, recruited from the department of Mathematics.